Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,515 INR | -0.33% | +2.88% | -3.56% |
Apr. 26 | Akzo Nobel India Limited Provides Update on Order from Assam GST Department | CI |
Apr. 20 | Akzo Nobel India Limited Receives Order from the Punjab GST Department | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Weaknesses
- With a 2024 P/E ratio at 26.22 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.56% | 1.38B | - | ||
-0.23% | 77.23B | C+ | ||
-13.89% | 34.2B | B- | ||
-7.15% | 16.16B | B | ||
-2.11% | 13.95B | B+ | ||
-15.90% | 11.26B | B+ | ||
+3.33% | 7.69B | B- | ||
-13.48% | 7.3B | B | ||
-14.01% | 2.83B | B- | ||
-13.37% | 2.76B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- AKZOINDIA Stock
- AKZOINDIA Stock
- Ratings Akzo Nobel India Limited